Expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) and its roles in activated microglia in vivo and in vitro

Journal of Neuroinflammation

Eng-Ang Ling¹  Chunyun Wu⁴  Jia Lu³  Enci Mary Kan³  Lijuan Yang² 

[1] Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore;Department of Pathology and Pathophysiology, Kunming Medical University, 1168 West Chunrong Road, Kunming 650500, Yunnan, P.R China;Defense Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510, Singapore;Department of Anatomy and Histology/Embryology, 1168 West Chunrong Road, Kunming 650500, Yunnan, P.R China

关键词: Anti-inflammation;    Inflammatory mediators;    Lipopolysaccharide;    Activated microglia;    CNPase;   

Others  :  1151070
DOI  :  10.1186/s12974-014-0148-9

 received in 2014-06-25, accepted in 2014-08-07,  发布年份 2014

【 摘 要 】

Background

We reported previously that amoeboid microglial cells in the postnatal rat brain expressed 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) both in vivo and in vitro; however, the functional role of CNPase in microglia has remained uncertain. This study extended the investigation to determine CNPase expression in activated microglia derived from cell culture and animal models of brain injury with the objective to clarify its putative functions.

Methods

Three-day-old Wistar rats were given an intraperitoneal injection of lipopolysaccharide to induce microglial activation, and the rats were killed at different time points. Along with this, primary cultured microglial cells were subjected to lipopolysaccharide treatment, and expression of CNPase was analyzed by real-time reverse transcription PCR and immunofluorescence. Additionally, siRNA transfection was employed to downregulate CNPase in BV-2 cells. Following this, inducible nitric oxide synthase, IL-1β and TNF-α were determined at mRNA and protein levels. Reactive oxygen species and nitric oxide were also assessed by flow cytometry and colorimetric assay, respectively. In parallel to this, CNPase expression in activated microglia was also investigated in adult rats subjected to fluid percussion injury as well as middle cerebral artery occlusion.

Results

In vivo, CNPase immunofluorescence in activated microglia was markedly enhanced after lipopolysaccharide treatment. A similar feature was observed in the rat brain after fluid percussion injury and middle cerebral artery occlusion. In vitro, CNPase protein and mRNA expression was increased in primary microglia with lipopolysaccharide stimulation. Remarkably, inducible nitric oxide synthase, IL-1β, TNF-α, reactive oxygen species and nitric oxide were significantly upregulated in activated BV-2 cells with CNPase knockdown. siRNA knockdown of CNPase increased microglia migration; on the other hand, microglial cells appeared to be arrested at G1 phase.

Conclusions

The present results have provided the first morphological and molecular evidence that CNPase expression is increased in activated microglia. CNPase knockdown resulted in increased expression of various inflammatory mediators. It is concluded that CNPase may play an important role as a putative anti-inflammatory gene both in normal and injured brain.

【 授权许可】

   
2014 Yang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Muller HW, Clapshaw PA, Seifert W: Two molecular forms of the isolated brain enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase. FEBS Lett 1981, 131:37-40.
• [2]Monoh K, Kurihara T, Sakimura K, Takahashi Y: Structure of mouse 2′,3′-cyclic-nucleotide 3′-phosphodiesterase gene. Biochem Biophys Res Commun 1989, 165:1213-1220.
• [3]O’Neill RC, Minuk J, Cox ME, Braun PE, Gravel M: CNP2 mRNA directs synthesis of both CNP1 and CNP2 polypeptides. J Neurosci Res 1997, 50:248-257.
• [4]Gravel M, DeAngelis D, Braun PE: Molecular cloning and characterization of rat brain 2′,3′-cyclic nucleotide 3′-phosphodiesterase isoform 2. J Neurosci Res 1994, 38:243-247.
• [5]Kurihara T, Monoh K, Sakimura K, Takahashi Y: Alternative splicing of mouse brain 2′,3′-cyclic-nucleotide 3′-phosphodiesterase mRNA. Biochem Biophys Res Commun 1990, 170:1074-1081.
• [6]McFerran B, Burgoyne R: 2′,3′-Cyclic nucleotide 3′-phosphodiesterase is associated with mitochondria in diverse adrenal cell types. J Cell Sci 1997, 110:2979-2985.
• [7]Brdiczka D, Beutner G, Ruck A, Dolder M, Wallimann T: The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition. Biofactors 1998, 8:235-242.
• [8]Halestrap AP, Brenner C: The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003, 10:1507-1525.
• [9]Wu CY, Lu J, Cao Q, Guo CH, Gao Q, Ling EA: Expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the amoeboid microglial cells in the developing rat brain. Neuroscience 2006, 142:333-341.
• [10]Cao Q, Ding P, Lu J, Dheen ST, Moochhala S, Ling EA: 2′,3′-Cyclic nucleotide 3′-phosphodiesterase cells derived from transplanted marrow stromal cells and host tissue contribute to perineurial compartment formation in injured rat spinal cord. J Neurosci Res 2007, 85:116-130.
• [11]Galvita A, Grachev D, Azarashvili T, Baburina Y, Krestinina O, Stricker R, Reiser G: The brain-specific protein, p42(IP4) (ADAP 1) is localized in mitochondria and involved in regulation of mitochondrial Ca2+. J Neurochem 2009, 109:1701-1713.
• [12]Lee J, Gravel M, Zhang R, Thibault P, Braun PE: Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 2005, 170:661-673.
• [13]Dreiling CE, Schilling RJ, Reitz RC: 2′,3′-cyclic nucleotide 3′-phosphohydrolase in rat liver mitochondrial membranes. Biochim Biophys Acta 1981, 640:114-120.
• [14]Azarashvili T, Krestinina O, Galvita A, Grachev D, Baburina Y, Stricker R, Evtodienko Y, Reiser G: Ca2 + −dependent permeability transition regulation in rat brain mitochondria by 2′,3′-cyclic nucleotides and 2′,3′-cyclic nucleotide 3′-phosphodiesterase. Am J Physiol Cell Physiol 2009, 296:C1428-C1439.
• [15]Halestrap AP: Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006, 34:232-237.
• [16]Dheen ST, Kaur C, Ling EA: Microglial activation and its implications in the brain diseases. Curr Med Chem 2007, 14:1189-1197.
• [17]Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C: The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002, 202:13-23.
• [18]Kim YS, Joh TH: Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease. Exp Mol Med 2006, 38:333-347.
• [19]Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P: Imaging microglial activation in Huntington’s disease. Brain Res Bull 2007, 72:148-151.
• [20]Colton CA, Gilbert DL: Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987, 223:284-288.
• [21]Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA: Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 2005, 50:21-31.
• [22]Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S: The role of glial cells in Parkinson’s disease. Curr Opin Neurol 2001, 14:483-489.
• [23]Wu YP, Ling EA: Transsynaptic changes of neurons and associated microglial reaction in the spinal cord of rats following middle cerebral artery occlusion. Neurosci Lett 1998, 256:41-44.
• [24]Saura J, Tusell JM, Serratosa J: High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
• [25]Nakamura Y, Si QS, Kataoka K: Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci Res 1999, 35:95-100.
• [26]Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C-T method. Nat Protoc 2008, 3:1101-1108.
• [27]Sakamoto Y, Tanaka N, Ichimiya T, Kurihara T, Nakamura KT: Crystal structure of the catalytic fragment of human brain 2′,3′-cyclic-nucleotide 3′-phosphodiesterase. J Mol Biol 2005, 346:789-800.
• [28]Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B: Neocortical glial cell numbers in human brains. Neurobiol Aging 2008, 29:1754-1762.
• [29]Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004, 101:6062-6067.
• [30]Vogel US, Thompson RJ: Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase. J Neurochem 1988, 50:1667-1677.
• [31]Sprinkle TJ, Agee JF, Tippins RB, Chamberlain CR, Faguet GB, De Vries GH: Monoclonal antibody production to human and bovine 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase): high-specificity recognition in whole brain acetone powders and conservation of sequence between CNP1 and CNP2. Brain Res 1987, 426:349-357.
• [32]Lee J, O’Neill RC, Park MW, Gravel M, Braun PE: Mitochondrial localization of CNP2 is regulated by phosphorylation of the N-terminal targeting signal by PKC: implications of a mitochondrial function for CNP2 in glial and non-glial cells. Mol Cell Neurosci 2006, 31:446-462.
• [33]Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
• [34]Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M: Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006, 9:268-275.
• [35]Urrutia PJ, Mena NP, Nunez MT: The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol 2014, 5:38.
• [36]Koizumi S, Ohsawa K, Inoue K, Kohsaka S: Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors. Glia 2013, 61:47-54.
• [37]Dibaj P, Nadrigny F, Steffens H, Scheller A, Hirrlinger J, Schomburg ED, Neusch C, Kirchhoff F: NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia 2010, 58:1133-1144.
• [38]Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF: The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007, 48:751-762.
• [39]Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A: Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 2006, 281:21362-21368.
• [40]Ohshima H, Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305:253-264.
• [41]Fujii T, Iwane AH, Yanagida T, Namba K: Direct visualization of secondary structures of F-actin by electron cryomicroscopy. Nature 2010, 467:724-728.
• [42]Mullins RD, Hansen SD: In vitro studies of actin filament and network dynamics. Curr Opin Cell Biol 2013, 25:6-13.
• [43]Baima ET, Guzova JA, Mathialagan S, Nagiec EE, Hardy MM, Song LR, Bonar SL, Weinberg RA, Selness SR, Woodard SS, Chrencik J, Hood WF, Schindler JF, Kishore N, Mbalaviele G: Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides. J Biol Chem 2010, 285:13498-13506.
• [44]Lee JW, Lee MS, Kim TH, Lee HJ, Hong SS, Noh YH, Hwang BY, Ro JS, Hong JT: Inhibitory effect of inflexinol on nitric oxide generation and iNOS expression via inhibition of NF-kappaB activation. Mediators Inflamm 2007, 2007:93148.
• [45]Dokic I, Hartmann C, Herold-Mende C, Regnier-Vigouroux A: Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Glia 2012, 60:1785-1800.
• [46]Shen SC, Wu MS, Lin HY, Yang LY, Chen YH, Chen YC: Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.J Cell Physiol 2014. doi: 10.1002/jcp.24659.
• [47]Naik E, Dixit VM: Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 2011, 208:417-420.
• [48]Tschopp J: Mitochondria: sovereign of inflammation? Eur J Immunol 2011, 41:1196-1202.
• [49]Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
• [50]Brown GC, Bal-Price A: Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003, 27:325-355.
• [51]Park GB, Bang SR, Lee HK, Kim D, Kim S, Kim JK, Kim YS, Hur DY: Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation. J Immunother 2014, 37:309-320.